Advertisement

Zynerba Pharmaceuticals, Inc. ZYNE

Set alert

Price alert · ZYNE

All alert types
1.30 +1.30 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
70.12M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-2.28
Beta
1.19
Short ratio
0.45
Inst. own
12.13%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2023
50-d avg
1.21
200-d avg
0.62141
1y target
1.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ZYNE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $255.96KExpenses → Selling, General & Admin: $3.26MExpenses → Research & Development: $4.88MGross Profit → Expenses: $86.00KRevenue → Gross Profit: $86.00KNet Loss → Expenses: $7.79MOther Income$255.96KGross Profit$86.00KNet Loss$7.79MExpenses$8.13MSelling, General & Admin$3.26MResearch & Development$4.88MRevenue$86.00K

Period ending Jun 30, 2023 · select a line to chart its history

Income statement

ZYNE quarterly income statement
11.14M
7.17M
3.97M
-11.14M
-10.78M
-10.78M
-10.78M
-10.78M
-0.21
-0.21
-0.21
-10.78M
-10.78M
50.15M
50.15M

Balance sheet

ZYNE quarterly balance sheet
35.97M
35.97M
39.29M
613.94K
40.48M
217.88K
217.88K
11.46M
11.46M
-295.41M
29.02M
29.02M
1.18M
217.88K
2.48M
1.88M

Cash flow

ZYNE quarterly cash flow
65.69K
-6.71K
-8.43M
-8.40K
61.50K
-68.21K
-8.40K
-8.42M
768.58K
Advertisement